麻豆社

麻豆社welcomes the Innovation Ecosystem Programme Review

NHS England published the Review today. The publication recommends a package of measures to help the UK lead the way in health innovation and generate economic growth.听

The ABPI's Chief Executive Richard Torbett was on the programme advisory group.

Welcoming today's report, Richard said: 鈥淭his review rightly recognises the scale and breadth of innovations coming through from the life sciences sector. It鈥檚 great to see the recommendations focus on making innovation a core NHS priority, ensuring breakthrough treatments can reach patients.

"To truly embed a culture of innovation in the NHS, the health system needs to foster the right skills and capabilities for staff to explore and embrace change.

鈥淢edicines and vaccines can support the three strategic shifts the Health Secretary wants to see. It is important for the NHS 10-Year Plan and the Innovation and Adoption Strategy to take the recommendations forward to help the NHS genuinely lead healthcare innovation on a global scale.鈥

TAGS
  • Innovation

Last modified: 28 November 2024

Last reviewed: 28 November 2024

The 麻豆社exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future.听

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines.听Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.